PKH1 Antibody

What is PKH1 and what cellular functions does it regulate?

PKH1 is a yeast protein kinase that serves as a homolog to mammalian PDK1 (3-phosphoinositide-dependent protein kinase-1). It functions primarily within sphingoid base-mediated signaling pathways that are required for the internalization step of endocytosis . PKH1 forms a functionally redundant kinase pair with PKH2, with both enzymes showing overlapping roles in yeast cells.

The signaling function of PKH1 centers on its ability to phosphorylate and activate Pkc1p (protein kinase C) in response to sphingoid bases like phytosphingosine (PHS) . This activation cascade plays critical roles in multiple cellular processes:

• Regulating endocytosis mechanisms

• Mediating responses to sphingolipid signaling

• Influencing actin cytoskeleton organization

• Potentially participating in cell stress responses

PKH1 activity is directly modulated by sphingoid bases, as demonstrated through in vitro phosphorylation assays where PKH1-mediated phosphorylation of Pkc1p increases significantly in the presence of phytosphingosine . This places PKH1 as a central component in sphingolipid-responsive signaling networks.

What experimental applications are PKH1 antibodies most commonly used for?

PKH1 antibodies facilitate several critical experimental applications in cell signaling and molecular biology research:

• Protein expression analysis: Western blotting with PKH1 antibodies enables detection and quantification of PKH1 expression levels. In research settings, epitope tagging of PKH1 (such as with triple hemagglutinin tags) facilitates reliable detection .

• Immunoprecipitation for kinase assays: PKH1 antibodies are used to isolate the kinase for subsequent activity measurements. The search results describe experiments where immunoprecipitated PKH1 was used to assess phosphorylation of Pkc1p substrate, with activity modulated by sphingoid bases .

• Signaling pathway analysis: PKH1 antibodies help elucidate components and regulation of sphingoid base-mediated signaling cascades. Researchers use antibodies to monitor PKH1's role in activating downstream effectors like Pkc1p in response to sphingolipid signals .

• Genetic manipulation verification: When researchers alter PKH1 gene expression (through overexpression or knockdown), antibodies provide critical verification of the resulting protein levels. For instance, in studies examining PKH1 overexpression effects on endocytosis in lcb1-100 mutant cells, antibodies confirm increased protein expression .

• Co-immunoprecipitation studies: Antibodies against PKH1 allow researchers to isolate protein complexes containing PKH1, helping identify interaction partners and regulatory associations.

How should researchers select appropriate PKH1 antibodies for their specific experiments?

When selecting PKH1 antibodies for research applications, several critical factors should be considered:

• Application compatibility: Different experimental techniques require antibodies with specific characteristics. For western blotting, high specificity is critical, while immunoprecipitation may require antibodies that recognize native conformations. The research demonstrates that antibodies used for PKH1 detection in western blotting were effective at dilutions around 1:500 .

• Epitope considerations:

  • For detecting total PKH1 protein, antibodies targeting conserved regions ensure consistent detection

  • For species-specific studies, choose antibodies raised against species-relevant epitopes

  • Consider whether the epitope might be masked by protein interactions or conformational changes

• Validation documentation: Select antibodies with thorough validation data including:

  • Positive controls showing detection in systems with known PKH1 expression

  • Negative controls demonstrating absence of signal in PKH1-deficient samples

  • Cross-reactivity testing, particularly with the closely related PKH2

• Tagged protein detection: For studies using epitope-tagged PKH1 (such as PKH1-HA₃), high-quality anti-tag antibodies (such as anti-HA) often provide more reliable detection than direct PKH1 antibodies .

• Phosphorylation-state specific detection: For analyzing PKH1 activation, consider phospho-specific antibodies similar to those available for other kinases, such as the Casein Kinase 1 alpha phospho T321 antibody mentioned in the search results .

What are the optimal conditions for using PKH1 antibodies in in vitro kinase assays?

Effective in vitro kinase assays with PKH1 require carefully optimized conditions to maintain enzyme activity and achieve reliable results. Based on the methodologies described in the search results, researchers should consider:

• Kinase immunoprecipitation:

  • Epitope-tagged PKH1 (such as PKH1-HA₃) is efficiently immunoprecipitated using anti-tag antibodies

  • Cell lysis should be performed in buffers containing 40 mM MOPS pH 7.5, 1 mM DTT, and 10 mM MgCl₂ to preserve kinase activity

  • Immune complexes containing PKH1 are collected on protein A/G beads

  • Gentle washing preserves kinase activity while removing non-specific binding

• Substrate preparation:

  • Natural substrates like Pkc1p can be similarly immunoprecipitated (as demonstrated with Pkc1p-HA₃)

  • Equal amounts of kinase beads are mixed with substrate beads for the reaction

  • Appropriate negative controls include kinase-dead mutants (such as pkh2-KR)

• Reaction conditions:

  • Buffer containing 40 mM MOPS pH 7.5, 1 mM DTT, and 10 mM MgCl₂

  • Addition of ATP (1 mM) and [γ-³²P]ATP (4 μCi) for radioactive detection

  • Sphingoid bases like phytosphingosine (PHS) at various concentrations (0.5-1000 nM) to study their modulatory effects

  • Pre-incubation with sphingoid bases for 10 minutes at room temperature

  • Reaction time of 30 minutes at room temperature

• Detection methods:

  • SDS-PAGE separation followed by washing in trichloroacetic acid (12.5%) and destaining solution

  • Phosphorylation quantification using a Cyclone Storage Phosphor Imager or similar technology

  • Western blot analysis of total lysate and immune complexes using anti-HA antibody to confirm protein levels

The research demonstrated that PKH1-mediated phosphorylation of Pkc1p increased in response to increasing concentrations of phytosphingosine, confirming the sphingoid base-dependent regulation of PKH1 activity .

How can researchers overcome background issues in PKH1 western blotting experiments?

Background problems are common challenges in antibody-based detection. For PKH1 antibodies, several strategies can help minimize background and improve signal-to-noise ratio:

• Optimized blocking protocols:

  • Test different blocking agents (BSA, non-fat dry milk, casein, commercial blocking buffers)

  • Extend blocking time (overnight at 4°C if necessary)

  • Include 0.1-0.3% Tween-20 in blocking buffer

• Antibody dilution optimization:

  • Perform titration experiments to determine optimal antibody concentration

  • For western blotting, starting dilutions of 1:500 are typical but may need adjustment

  • Dilute antibodies in fresh blocking buffer

• Enhanced washing procedures:

  • Increase wash number and duration (5-6 washes of 5-10 minutes each)

  • Use TBS-T with higher Tween-20 concentration (0.1-0.3%)

  • Include salt (up to 500 mM NaCl) in wash buffers to reduce ionic interactions

• Sample preparation refinements:

  • Ensure complete protein denaturation

  • Remove particulates by centrifugation before loading

  • Consider using gradient gels for better protein separation

  • For epitope-tagged PKH1 (such as PKH1-HA₃), anti-tag antibodies often provide cleaner detection

• Control experiments:

  • Include pre-absorption controls where antibody is pre-incubated with immunizing peptide

  • Run parallel blots with secondary antibody only

  • Include lysates from PKH1-deficient cells as negative controls

The research demonstrates successful detection of epitope-tagged PKH1 and PKH2 using anti-HA antibodies in western blotting applications, with sample lysates prepared carefully to maintain protein integrity .

What controls are essential when using PKH1 antibodies in signaling pathway analysis?

Proper controls are essential for interpreting and validating PKH1 antibody experiments in signaling pathway analysis. Based on the research methodologies described, the following controls should be included:

The research demonstrates the importance of these controls by including vehicle controls in sphingoid base activation studies, using kinase-dead mutants as negative controls, and comparing multiple kinases to establish the specificity of PKH1/2 in sphingoid base signaling .

How do researchers use PKH1 antibodies to elucidate sphingoid base-mediated signaling?

PKH1 antibodies serve as critical tools for dissecting the mechanisms of sphingoid base-mediated signaling pathways. The research demonstrates several specific approaches:

• In vitro activation studies:

  • Immunoprecipitated PKH1 (using antibodies against tagged PKH1) is used in kinase assays with increasing concentrations of phytosphingosine (PHS)

  • These assays revealed that PKH1 activity toward Pkc1p increases in the presence of sphingoid bases

  • Dose-response experiments with PHS concentrations ranging from 0.5 to 1000 nM establish the sensitivity of PKH1 to sphingoid base activation

• Pathway component identification:

  • Immunoprecipitation with PKH1 antibodies followed by western blotting identifies interaction partners

  • The research establishes that PKH1 directly phosphorylates Pkc1p, connecting these components in a signaling pathway

  • Comparative analysis of PKH1 and PKH2 determines their relative contributions to the pathway

• Genetic-biochemical correlation:

  • Western blotting confirms PKH1 expression in genetic experiments where PKH1 overexpression suppresses phenotypes of sphingolipid synthesis mutants (lcb1-100)

  • This approach establishes that PKH1 functions downstream of sphingolipid synthesis in the signaling pathway

• Specificity determination:

  • Comparison with other kinases (Skm1p, casein kinase II) that are activated by sphingosine in mammalian systems demonstrates the specificity of PKH1/2 in yeast sphingoid base signaling

  • The research showed that unlike PKH1/2, overexpression of Skm1p (a yeast PAK1 homolog) did not suppress the endocytic defect of lcb1-100 mutants

• Functional correlation:

  • The research correlates PKH1 activity with cellular functions like endocytosis (α-factor internalization) and actin cytoskeleton organization

  • This creates a comprehensive understanding of how sphingoid base signals are transduced through PKH1 to affect cellular processes

What techniques help researchers investigate the relationship between PKH1 and downstream effectors?

The relationship between PKH1 and its downstream effectors, particularly Pkc1p, represents a critical node in sphingolipid signaling. Researchers employ several antibody-dependent techniques to investigate these relationships:

• In vitro kinase assays:

  • Immunoprecipitated PKH1 (using anti-tag antibodies) is mixed with immunoprecipitated Pkc1p as substrate

  • Phosphorylation is detected using [γ-³²P]ATP incorporation and phosphorimaging

  • These assays demonstrated that PKH1 directly phosphorylates Pkc1p, and this activity is enhanced by sphingoid bases like phytosphingosine

• Genetic interaction studies with biochemical validation:

  • The research showed that temperature sensitivity of pkh-ts (pkh1-ts pkh2Δ) mutants is partially suppressed by a PKC1-R398P dominant mutation

  • Western blotting confirms expression of the relevant proteins in these genetic backgrounds

  • This genetic interaction supports a functional relationship between PKH1 and PKC1

• Comparative functional analysis:

  • The research demonstrates that both PKH1 and PKC1 overexpression suppress the endocytic defect in lcb1-100 mutant cells

  • The α-factor uptake rate displayed by lcb1-100 cells overexpressing PKH1 is similar to that of cells overexpressing PKC1, suggesting they act in the same pathway

  • In contrast, PKH2 overexpression produced effects more similar to YCK2 overexpression

• Pathway reconstruction:

  • By combining genetic evidence (suppression studies) with biochemical evidence (kinase assays), researchers established that sphingoid bases activate PKH1, which then phosphorylates and activates Pkc1p

  • This pathway is required for the internalization step of endocytosis and proper actin cytoskeleton organization

• Cross-species comparison:

  • The research notes similarities between the yeast PKH1-Pkc1p pathway and mammalian PDK1 activation by sphingosine

  • This comparative approach helps establish evolutionarily conserved signaling mechanisms

How can PKH1 antibodies be used to study the role of PKH1 in endocytosis?

PKH1 antibodies facilitate the investigation of sphingoid base-mediated regulation of endocytosis through several experimental approaches:

• Expression correlation studies:

  • Western blotting with antibodies against tagged PKH1 confirms expression levels in cells with altered endocytic function

  • The research demonstrates that PKH1 overexpression partially restores α-factor internalization in sphingolipid synthesis-defective lcb1-100 mutant cells at 37°C

  • Quantitative comparison showed that the suppressor effect of PKH1 was similar to that of PKC1 but less potent than PKH2 or YCK2

• Pathway component analysis:

  • The research established that PKH1 functions in the same pathway as sphingolipids and PKC1 in regulating endocytosis

  • This was demonstrated by genetic evidence (suppression studies) combined with biochemical evidence (in vitro kinase assays)

  • The study showed that PKH1's role in endocytosis is specific, as other kinases activated by sphingosine in mammalian systems (Skm1p, casein kinase II) could not suppress the endocytic defect

• Functional assays with antibody verification:

  • [³⁵S]α-factor internalization assays measure endocytosis rates in cells with altered PKH1 expression

  • Antibodies confirm the expression levels of PKH1 in these experimental systems

  • The research showed that while PKH1 overexpression restored endocytosis, it did not suppress the temperature-sensitive growth phenotype of lcb1-100 mutants, indicating a specific role in endocytosis

• Actin cytoskeleton studies:

  • The research mentions that overexpression of PKH1/2 kinases restores organization of the actin cytoskeleton in lcb1-100 mutant cells

  • This suggests a mechanism by which PKH1 regulates endocytosis through actin organization

  • Antibodies verify PKH1 expression in these experiments

• Comparative analysis:

  • The research compares multiple kinases (PKH1, PKH2, Skm1p, Yck2p, Pkc1p) for their ability to suppress endocytic defects

  • This comparative approach, supported by antibody verification of expression levels, establishes the specific roles of different kinases in endocytosis regulation

What are common challenges in PKH1 antibody-based experiments and how can they be addressed?

Researchers working with PKH1 antibodies may encounter several technical challenges that require specific troubleshooting approaches:

• Low abundance detection:

  • Challenge: Endogenous PKH1 may be expressed at low levels, making detection difficult

  • Solution: Use epitope tagging strategies, as demonstrated in the research with HA-tagged PKH1 (PKH1-HA₃)

  • Solution: Employ signal amplification methods such as enhanced chemiluminescence or tyramide signal amplification

• Specificity concerns:

  • Challenge: Antibodies may cross-react with related kinases, particularly PKH2

  • Solution: Validate antibody specificity using PKH1 deletion strains

  • Solution: Compare results with multiple antibodies targeting different epitopes

  • Solution: Use epitope-tagged versions when possible, as demonstrated in the research

• Activity preservation:

  • Challenge: Maintaining PKH1 kinase activity during immunoprecipitation

  • Solution: Use gentle lysis conditions (40 mM MOPS pH 7.5, 1 mM DTT, 10 mM MgCl₂)

  • Solution: Minimize time between lysis and kinase assay

  • Solution: Include phosphatase inhibitors when studying phosphorylation states

• Variable results in functional assays:

  • Challenge: Inconsistent outcomes in PKH1 overexpression experiments

  • Solution: Carefully control expression levels through western blot verification

  • Solution: Include positive controls (such as PKC1 overexpression) for comparison

  • Solution: Perform multiple biological replicates (the research notes that all phosphorylation assays were performed at least twice)

• Background in complex samples:

  • Challenge: High background when detecting PKH1 in cell lysates

  • Solution: Optimize antibody dilution (typically starting at 1:500 for western blotting)

  • Solution: Use more stringent washing procedures

  • Solution: Consider immunoprecipitation before western blotting to enrich for PKH1

How should researchers design experiments to study PKH1 phosphorylation states?

Detecting and analyzing PKH1 phosphorylation states presents unique challenges that require careful experimental design:

• Phospho-specific antibody selection:

  • While the search results don't specifically mention phospho-PKH1 antibodies, the principles can be inferred from other phospho-specific antibodies like the Casein Kinase 1 alpha phospho T321 antibody

  • Consider antibodies raised against synthetic phosphopeptides corresponding to known or predicted PKH1 phosphorylation sites

  • Validate phospho-specificity using phosphatase treatment controls

• Phosphorylation site mapping:

  • Use mass spectrometry approaches to identify PKH1 phosphorylation sites

  • Immunoprecipitate PKH1 (using epitope tags as in the research) for subsequent phosphorylation site analysis

  • Compare phosphorylation patterns under different conditions (with/without sphingoid base treatment)

• Stimulus-response experiments:

  • Design time-course experiments to capture dynamic phosphorylation changes

  • Include sphingoid base treatments at physiologically relevant concentrations (0.5-1000 nM as used in the research)

  • Compare wild-type PKH1 with phosphorylation site mutants to determine functional significance

• Technical considerations:

  • Include phosphatase inhibitors in all buffers

  • Use Phos-tag SDS-PAGE to enhance separation of phosphorylated from non-phosphorylated forms

  • Consider 2D electrophoresis to resolve different phospho-isoforms

  • Include appropriate controls (phosphatase-treated samples, kinase-dead mutants)

• Functional correlation:

  • Correlate PKH1 phosphorylation states with kinase activity measurements

  • Compare phosphorylation patterns with functional outcomes (such as endocytosis rates)

  • Investigate how sphingoid base treatment affects both phosphorylation status and functional activity

What specialized techniques help maximize information from limited PKH1 antibody resources?

When working with limited antibody resources or challenging detection scenarios, researchers can employ several specialized techniques to maximize information yield:

• Epitope tagging strategies:

  • The research demonstrates successful use of triple HA-tagged PKH1 (PKH1-HA₃)

  • This approach enables detection with highly specific and widely available anti-HA antibodies

  • Functional validation showed that PKH1-HA₃ constructs retained biological activity

• Signal amplification methods:

  • Tyramide signal amplification can enhance detection sensitivity for immunoblotting or immunofluorescence

  • Biotin-streptavidin systems provide amplification for detection of low-abundance proteins

  • Polymer-based detection systems can increase signal without increasing background

• Sample enrichment approaches:

  • Immunoprecipitation before western blotting concentrates the protein of interest

  • Subcellular fractionation can enrich for PKH1 in relevant cellular compartments

  • Phosphoprotein enrichment techniques when studying phosphorylated forms

• Multiplexing strategies:

  • Multiplex western blotting allows detection of multiple proteins on the same membrane

  • Multiple fluorescent labels enable simultaneous detection of PKH1 along with interacting partners

  • Sequential probing of the same blot with different antibodies (stripping and reprobing)

• Alternative detection platforms:

  • Proximity ligation assays can detect protein interactions with higher sensitivity than co-immunoprecipitation

  • In-cell western techniques for higher throughput analysis

  • Flow cytometry-based approaches for single-cell resolution of PKH1 expression or modification

The research demonstrates successful application of these principles through the use of epitope tagging (HA tags) combined with immunoprecipitation to isolate PKH1 for subsequent activity measurements in kinase assays .

How are new antibody technologies enhancing PKH1 research capabilities?

Recent advances in antibody technology are expanding PKH1 research capabilities in several important ways:

• Recombinant antibody approaches:

  • The search results describe a "Golden Gate-based dual-expression vector and in-vivo expression of membrane-bound antibodies" for rapid screening of recombinant monoclonal antibodies

  • Such technologies could accelerate development of more specific PKH1 antibodies

  • The method demonstrated "rapid isolation of influenza cross-reactive antibodies with high affinity from immunized mice within 7 days"

  • Similar approaches could yield high-affinity PKH1 antibodies with enhanced specificity

• Single-cell antibody discovery:

  • The research mentions collection of "374 IgG1+ B cells... in a single-cell fashion" with successful sequencing of 284 independent clones

  • Such techniques could facilitate development of diverse antibody repertoires against PKH1

  • Single-cell approaches enable isolation of rare but highly specific antibodies

• Genotype-phenotype linked systems:

  • The "genotype–phenotype linked antibody discovery system" described could accelerate production of PKH1-specific antibodies

  • This system connects antibody sequences directly to binding phenotypes

  • The approach "is particularly useful for isolating therapeutic or diagnostic antibodies"

• In vivo expression systems:

  • The research describes "in-vivo expression of membrane-bound antibodies" for rapid screening

  • Such methods allow functional testing of antibodies without requiring extensive purification

  • The approach described used a Venus fluorescent protein fusion to enable flow cytometric sorting of antibody-expressing cells

• Multiple epitope targeting:

  • Advanced antibody development allows targeting of multiple PKH1 epitopes simultaneously

  • This enhances detection capabilities and provides redundancy in detection systems

  • Combinatorial approaches yield more comprehensive information about PKH1 expression and modification

What are potential new research areas where PKH1 antibodies may provide critical insights?

While the search results don't explicitly describe novel applications of PKH1 antibodies, they suggest several promising research directions:

• Integrated signaling networks:

  • PKH1 antibodies could help map connections between sphingolipid signaling and other major cellular pathways

  • The research mentions PKH1/2 as "a positive regulator of mTORC1 and mTORC2 signaling in response to nutrients"

  • PKH1 antibodies could help investigate cross-talk between nutrient sensing and sphingolipid signaling

• Metabolic regulation studies:

  • PKH1's connections to nutrient signaling suggest roles in cellular metabolism

  • Antibodies could track PKH1 activity in response to various metabolic states

  • Investigation of PKH1's potential roles in metabolic adaptation mechanisms

• Stress response mechanisms:

  • PKH1's role in endocytosis may connect to cellular stress responses

  • The research mentions PKH1 as "an inhibitor of NLRP3 inflammasome assembly"

  • Antibodies could help track PKH1 activation during various cellular stresses

  • Investigation of connections between sphingolipid signaling and stress adaptation

• Comparative evolutionary studies:

  • PKH1 antibodies could enable comparison of sphingolipid signaling mechanisms across species

  • The research notes similarities between yeast PKH1-Pkc1p signaling and mammalian PDK1 activation by sphingosine

  • Investigation of functional conservation and divergence in sphingolipid signaling

• Pharmacological intervention strategies:

  • PKH1 antibodies could support screening and validation of compounds targeting sphingolipid signaling

  • Development of tools to monitor pathway modulation in response to therapeutic agents

  • Exploration of PKH1 pathway components as potential drug targets

How can PKH1 antibodies contribute to understanding disease mechanisms?

PKH1 antibodies have potential applications in understanding disease mechanisms, particularly through analysis of mammalian homologs and conserved signaling pathways:

• Cancer signaling pathway analysis:

  • The search results mention that PKH1 "acts as a positive regulator of mTORC1 and mTORC2 signaling"

  • mTOR signaling is frequently dysregulated in cancer

  • Antibodies against PKH1 homologs could help investigate sphingolipid-mediated regulation of cancer cell growth and survival

• Neurodegenerative disease research:

  • Sphingolipid metabolism is implicated in several neurodegenerative conditions

  • PKH1 homologs may participate in neuronal sphingolipid signaling

  • Antibodies could track alterations in these pathways in disease models

• Inflammatory conditions:

  • The search results mention PKH1 as "an inhibitor of NLRP3 inflammasome assembly"

  • NLRP3 inflammasome is implicated in various inflammatory diseases

  • Antibodies could help investigate how sphingolipid signaling modulates inflammatory responses

• Metabolic disorders:

  • Connections between PKH1, sphingolipid signaling, and nutrient sensing suggest potential roles in metabolic regulation

  • Antibodies could track alterations in these pathways in metabolic disease models

  • Investigation of therapeutic interventions targeting these pathways

• Infectious disease mechanisms:

  • PKH1's role in endocytosis may connect to pathogen entry mechanisms

  • Antibodies could track how pathogens manipulate host sphingolipid signaling

  • Development of intervention strategies targeting host-pathogen interactions through sphingolipid pathways